AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Labomar

AGM Information Apr 28, 2023

4144_rns_2023-04-28_87520924-4aef-4518-b21a-110647037f7c.pdf

AGM Information

Open in Viewer

Opens in native device viewer

Comunicato stampa

Ordinary Shareholders' Meeting deserted on first call, postponement to second call and new deadlines for issuing proxies to the Designated Representative

Istrana (TV), April 28, 2023 — Labomar SpA (Ticker: LBM), an Italian-based international nutraceutical enterprise and listed on the Euronext Growth Milan market, announces that the Ordinary Shareholders' Meeting, convened for today on first call at 12.00 am at the offices of the production site located in Via F. Filzi, 55/A, Istrana (TV), was not validly constituted due to lack in the quorum prescribed by law.

As indicated in the call notice, the Shareholders' Meeting will therefore be held on second call on May 4, 2023 at 9.00 am, same place.

For the methods and deadlines for issuing proxies to the exclusive Designated Representative, please refer to the call notice published in accordance with current legislation (and available on the Company's website www.labomar.com, in the "Governance / Shareholders' Meeting" section).

Labomar profile

Founded by Walter Bertin in Istrana (province of Treviso) in 1998, Labomar is specialised in the development and production of food supplements, medical devices, foods for special medical purposes and cosmetics for third parties. Over more than 20 years, Labomar has built a business model which sets it apart from its competitors and generates value for all stakeholders, providing a comprehensive service and a high quality and productivity standard. The company boasts a well-structured and cutting-edge research and development department with a particular focus on innovation, a commercial team which reacts quickly to market demands and a high level of product differentiation thanks to its proprietary patents and formulas.

Following the acquisitions of the Welcare Group and Labiotre Srl, in addition to the establishment of LaboVar Srl, in 2022 Labomar focused on maximising the synergies among the various companies, pooling resources and expertise to expand its product portfolio, enter new markets and streamline certain processes, including through the best practices brought by each of the Group companies.

Labomar whole-heartedly believes in a business system based on sustainability and a real concern for people, the environment and the community. It therefore by 2020 had gained Benefit Company status and simultaneously embarked on obtaining B Corp Certification, for which it has already applied to the relative body for certification issuance. This is testament to the company's choice to become part of a global movement of companies that respect high standards of social and environmental impact.

For further information:

Labomar Press Office Thanai Bernardini - +39.335.7245418 - [email protected] Alessandro Bozzi Valenti - +39.348.0090866 - [email protected] Margherita Bertolo - +39.328.5574976 - [email protected]

Investor Relations Labomar Claudio De Nadai - +39.0422.677203 - [email protected] Mara Di Giorgio - +39 335 7737417 - [email protected]

Euronext Growth Advisor Banca Mediolanum - +39 02 9049 2525 - [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.